Michael Schroeder

Merck & Co is preparing the launch of Gardasil, the first human papillomavirus (HPV) vaccine. Because knowledge of HPV is poor among potential vaccinees and other stakeholders (parents, physicians, third-party payers), and there is no habit of vaccinating adolescents, Merck needs to develop pre-launch programmes.

Published 26 Jan 2015

Reference 5795

Topic Marketing

Industry Pharmaceuticals

Region North America

View case